FGFR1 and pancreatic adenocarcinoma: Hence, we used the cBioPortal for cancer genomics (https://www.cbioportal.org/) to analyze FGFR1 and PARP1 expression and their functional association with selected markers of cancer stemness, resistance to therapy, and DNA repair by using the provisional TCGA pancreatic adenocarcinoma cohort (n = 185 patients/186 samples).